Red Capital's Life Science and Healthcare Fund 'Red No. 1 Healthcare Investment Limited Partnership' Welcomes Organization for Small & Medium Enterprises and Regional Innovation (SME Support JAPAN) — Accelerating Fund Expansion and Ecosystem Collaboration
SME Support JAPAN joins Red Capital's healthcare-focused fund, accelerating the fund's growth and ecosystem development.
📋 Article Processing Timeline
- 📰 Published: March 28, 2026 at 16:00
- 🔍 Collected: March 28, 2026 at 21:59 (5h 58m after Published)
- 🤖 AI Analyzed: April 15, 2026 at 06:11 (416h 11m after Collected)

Red Capital Inc. (Headquarters: Shibuya-ku, Tokyo) is pleased to announce that the Organization for Small & Medium Enterprises and Regional Innovation (SME Support JAPAN) has joined as a limited partner in the "Red No. 1 Healthcare Investment Limited Partnership" (hereinafter "Red No. 1 Fund"), a fund specializing in life sciences and healthcare.
With this new participation, the Red No. 1 Fund now includes SME Support JAPAN, Seibu Shinkin Bank, the University-based Startup Promotion Fund (managed by The University of Tokyo Edge Capital Partners Co., Ltd.), and The Shizuoka Bank, Ltd. as LPs. We will continue our fundraising activities with a target fund size of 6 billion yen.
■ Background and Vision of the Fund
Under the vision of "Taking humanity to the next stage," Red Capital established the Red No. 1 Fund to bridge science and technology in the life science and healthcare sectors with social implementation. While deep tech offers significant social impact, it requires long lead times and substantial capital to commercialize, and Japan currently lacks sufficient risk money and support systems to sustain such growth. The Red No. 1 Fund combines two investment approaches: a "Seed-Drive" model that provides consistent support from the seed stage to exit, and an "Ecosystem-Complementary" model that boosts growth through secondary investments. We provide long-term, optimal support tailored to each growth phase, going beyond mere capital injection. Furthermore, by discovering and nurturing excellent technological seeds scattered across regions, we contribute to the creation of new industries and the revitalization of regional economies. By integrating investment, hands-on support, and ecosystem collaboration, we aim to achieve both financial returns and social impact. It is Red Capital's mission to elevate the potential of scientific technology into tangible businesses and deliver those results to society.
■ Synergies with Participating LPs and Future Outlook
The participation of SME Support JAPAN is expected to accelerate cross-regional collaboration and the creation of new business opportunities by leveraging the organization's nationwide incubation facilities and extensive network. Additionally, through collaboration with the acceleration programs provided by SME Support JAPAN, we will further enhance our support for startup growth, increasing the speed toward commercialization and market entry. Utilizing this collaborative foundation, the Red No. 1 Fund will continue to expand its investment activities while enhancing the value-creation capacity of the entire ecosystem. We will continue to pursue LP recruitment to reach our 6 billion yen target, accelerating the social implementation of more innovative technologies.
■ Comments from Investors
Organization for Small & Medium Enterprises and Regional Innovation (SME Support JAPAN)
SME Support JAPAN is a policy implementation agency that supports the growth and development of SMEs and startups, as well as the revitalization of regional economies. For the Red No. 1 Healthcare Investment Limited Partnership, we have high expectations that the discovery of new technological seeds in drug discovery and medical devices, investment based on deep, paper-based due diligence, and hands-on support from the two experienced GPs will not only lead to the social implementation of excellent technologies from R&D-based startups but also contribute to the sustainable growth of the Japanese economy, industrial sophistication, and regional revitalization.
Seibu Shinkin Bank
We are very pleased to participate in supporting innovative startups in the life science and healthcare fields through our investment in this fund. We believe that Red Capital's deep expertise and diverse perspectives will empower ambitious entrepreneurs to take on challenges...
FAQ
Who recently joined as a limited partner in the Red No. 1 Healthcare Investment Limited Partnership?
The Organization for Small & Medium Enterprises and Regional Innovation, also known as SME Support JAPAN, joined as a limited partner.
What is the target fund size that Red Capital is continuing its fundraising activities to reach?
The target fund size for the Red No. 1 Healthcare Investment Limited Partnership is six billion yen.
What are the two investment approaches combined by the Red No. 1 Healthcare Investment Limited Partnership?
The fund combines a Seed-Drive model for seed-to-exit support and an Ecosystem-Complementary model for secondary investments.
What is the primary vision under which Red Capital established the Red No. 1 Healthcare Investment Limited Partnership?
The fund was established under the vision of taking humanity to the next stage by bridging science and technology with social implementation.
Which financial institutions and organizations are currently included as limited partners in the Red No. 1 Fund?
The LPs include SME Support JAPAN, Seibu Shinkin Bank, the University-based Startup Promotion Fund, and The Shizuoka Bank, Ltd.